• 4754 Citations
  • 38 h-Index
1980 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2019

An elective course in lesbian, gay, bisexual, and transgender health and practice issues

Jann, M. W., Penzak, S., White, A. & Tatachar, A., 1 Jan 2019, In : American journal of pharmaceutical education. 83, 8, p. 1723-1731 9 p., 6967.

Research output: Contribution to journalArticle

Selective serotonin reuptake inhibitor use and risk of gastrointestinal and intracranial bleeding

Yuet, W. C., Derasari, D., Sivoravong, J., Mason, D. & Jann, M., Feb 2019, In : Journal of the American Osteopathic Association. 119, 2, p. 102-111 10 p.

Research output: Contribution to journalReview article

3 Scopus citations

The Evolving Role of Pharmacists in Transgender Health Care

Redfern, J. S. & Jann, M. W., 11 Apr 2019, In : Transgender Health. 4, 1, p. 118-130 13 p.

Research output: Contribution to journalReview article

Open Access
2018

Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents

Jann, M. W. & Penzak, S. R., 1 Mar 2018, In : CNS Drugs. 32, 3, p. 241-257 17 p.

Research output: Contribution to journalReview article

12 Scopus citations
2016

Anesthetic drugs pharmacokinetics and pharmacodynamics

Jann, M. W., 1 Jan 2016, Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Springer International Publishing, p. 373-394 22 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Anti-addiction agents

Jann, M. W., 1 Jan 2016, Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Springer International Publishing, p. 351-372 22 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Antidementia drugs

van Den Berg, C. M. & Jann, M. W., 1 Jan 2016, Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Springer International Publishing, p. 329-349 21 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Antipsychotics

Jann, M. W. & Klugh Kennedy, W., 1 Jan 2016, Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Springer International Publishing, p. 139-175 37 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations
2 Scopus citations

Clinically significant interactions with anesthetic agents

Jann, M. W., 1 Jan 2016, Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Springer International Publishing, p. 579-601 23 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations

Clinical pharmacokinetics and pharmacodynamics of psychopharmacological drug classes

Jann, M. W., 1 Jan 2016, Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Springer International Publishing, 1 p.

Research output: Chapter in Book/Report/Conference proceedingForeword/postscript

Preface

Jann, M. W., Penzak, S. R. & Cohen, L. J., 1 Jan 2016, Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Springer International Publishing, p. v-vi

Research output: Chapter in Book/Report/Conference proceedingForeword/postscript

2015
22 Scopus citations
2014

Benzodiazepines: A major component in unintentional prescription drug overdoses with opioid analgesics

Jann, M., Kennedy, W. K. & Lopez, G., Feb 2014, In : Journal of Pharmacy Practice. 27, 1, p. 5-16 12 p.

Research output: Contribution to journalArticle

111 Scopus citations
33 Scopus citations

Unique collaboration between a private college of pharmacy and a private academic health system

Metzger, N., Paciullo, C., Chesson, M., Jann, M. W., Glascock, J., Emamifar, A. & Matthews, H. W., 1 Jan 2014, In : Hospital Pharmacy. 49, 7, p. 634-638 5 p.

Research output: Contribution to journalArticle

1 Scopus citations
2013

Clinically significant drug interactions with atypical antipsychotics

Kennedy, W. K., Jann, M. W. & Kutscher, E. C., 1 Dec 2013, In : CNS Drugs. 27, 12, p. 1021-1048 28 p.

Research output: Contribution to journalReview article

46 Scopus citations
38 Scopus citations
2012

Lack of a pharmacokinetic drug-drug interaction with venlafaxine extended-release/indinavir and desvenlafaxine extended-release/indinavir

Jann, M. W., Spratlin, V., Momary, K., Zhang, H., Turner, D., Penzak, S. R., Wright, A. & VanDenBerg, C., 1 May 2012, In : European Journal of Clinical Pharmacology. 68, 5, p. 715-721 7 p.

Research output: Contribution to journalArticle

7 Scopus citations
2011

Advanced strategies for treatment of Parkinson's disease: the role of early treatment.

Jann, M. W., 1 Jan 2011, In : The American journal of managed care. 17 Suppl 12

Research output: Contribution to journalReview article

7 Scopus citations

Maternal treatment with opioid analgesics and risk for birth defects

Broussard, C. S., Rasmussen, S. A., Reefhuis, J., Friedman, J. M., Jann, M. W., Riehle-Colarusso, T. & Honein, M. A., 1 Jan 2011, In : American Journal of Obstetrics and Gynecology. 204, 4, p. 314.e1-314.e11

Research output: Contribution to journalArticle

182 Scopus citations
2008

Disposition of D-serine in healthy adults

Tsai, G. E., Lane, H. Y., Vandenberg, C. M., Liu, Y. C., Tsai, P. & Jann, M. W., 1 Apr 2008, In : Journal of Clinical Pharmacology. 48, 4, p. 524-527 4 p.

Research output: Contribution to journalArticle

4 Scopus citations
2007

Antidepressant agents for the treatment of chronic pain and depression

Jann, M. W. & Slade, J. H., 1 Nov 2007, In : Pharmacotherapy. 27, 11, p. 1571-1587 17 p.

Research output: Contribution to journalReview article

124 Scopus citations
2006

Altered methylprednisolone pharmacodynamics in healthy subjects with Histamine N-Methyltransferase C314T genetic polymorphism

Yuen, Y. H., Jusko, W. J., Spratlin, V. E. & Jann, M. W., 1 Apr 2006, In : Journal of Clinical Pharmacology. 46, 4, p. 408-417 10 p.

Research output: Contribution to journalArticle

8 Scopus citations

Effect of thioridazine on gap junction intercellular communication in connexin 43-expressing cells

Matesic, D. F., Abifadel, D. N., Garcia, E. L. & Jann, M. W., 1 Jul 2006, In : Cell Biology and Toxicology. 22, 4, p. 257-268 12 p.

Research output: Contribution to journalArticle

2 Scopus citations

Endogenous histamine and cortisol levels in subjects with different histamine N-methyltransferase C314T genotypes: A pilot study

Yuen, Y. H., Jusko, W. J., Zhou, H. H., Chen, G. L., Guo, D., Zhou, G., Spratlin, V. E. & Jann, M. W., 9 May 2006, In : Molecular Diagnosis and Therapy. 10, 2, p. 109-114 6 p.

Research output: Contribution to journalArticle

6 Scopus citations

Galantamine extended release: A veiwpoint

Farlow, M. R., Jann, M. W., Lyketsos, C. G. & Kozauer, N. A., 3 Aug 2006, In : CNS Drugs. 20, 8, p. 682-683 2 p.

Research output: Contribution to journalComment/debate

Lack of pharmacokinetic interaction between lamotrigine and olanzapine in healthy volunteers

Jann, M. W., Hon, Y. Y., Shamsi, S. A., Zheng, J., Awad, E. A. & Spratlin, V., 1 May 2006, In : Pharmacotherapy. 26, 5 I, p. 627-633 7 p.

Research output: Contribution to journalArticle

15 Scopus citations

Reduced methylprednisolone clearance causing prolonged pharmacodynamics in a healthy subject was not associated with CYP3A5*3 allele or a change in diet composition

Lee, S. J., Jusko, W. J., Salaita, C. G., Calis, K. A., Jann, M. W., Spratlin, V. E., Goldstein, J. A. & Yuen, Y. H., 1 May 2006, In : Journal of Clinical Pharmacology. 46, 5, p. 515-526 12 p.

Research output: Contribution to journalArticle

11 Scopus citations
2004

Development of capillary zone electrophoresis-electrospray ionization-mass spectrometry for the determination of lamotrigine in human plasma

Zheng, J., Jann, M. W., Hon, Y. Y. & Shamsi, S. A., 1 Jul 2004, In : Electrophoresis. 25, 13, p. 2033-2043 11 p.

Research output: Contribution to journalArticle

43 Scopus citations

Dose-dependent alternations in the pharmacokinetics of olanzapine during coadministration of fluvoxamine in patients with schizophrenia

Chiu, C. C., Lane, H. Y., Huang, M. C., Liu, H. C., Jann, M. W., Hon, Y. Y., Chang, W. H. & Lu, M. L., 1 Dec 2004, In : Journal of Clinical Pharmacology. 44, 12, p. 1385-1390 6 p.

Research output: Contribution to journalArticle

21 Scopus citations

Implications for atypical antipsychotics in the treatment of schizophrenia: Neurocognition effects and a neuroprotective hypothesis

Jann, M. W., 1 Dec 2004, In : Pharmacotherapy. 24, 12 I, p. 1759-1783 25 p.

Research output: Contribution to journalReview article

38 Scopus citations
2003

Correlation of cytochrome p450 (CYP) ia2 activity using caffeine phenotyping and olanzapine disposition in healthyvolunteers

Shirley, K. L., Hon, Y. Y., Penzak, S. R., Francis Lam, Y. W., Spratlin, V. & Jann, M. W., May 2003, In : Neuropsychopharmacology. 28, 5, p. 961-966 6 p.

Research output: Contribution to journalArticle

49 Scopus citations
2002

Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors

Jann, M. W., Shirley, K. L. & Small, G. W., 1 Jan 2002, In : Clinical Pharmacokinetics. 41, 10, p. 719-739 21 p.

Research output: Contribution to journalReview article

258 Scopus citations

Clinical significance of drug binding, protein binding, and binding displacement drug interactions

Jann, M. W., 1 Jun 2002, In : Psychopharmacology bulletin. 36, 3, p. 22-41 20 p.

Research output: Contribution to journalArticle

7 Scopus citations

Dosing strategies of clozapine-fluvoxamine cotreatment [4]

Lu, M. L., Lane, H. Y., Jann, M. W. & Chang, W. H., 1 Dec 2002, In : Journal of Clinical Psychopharmacology. 22, 6, p. 626-628 3 p.

Research output: Contribution to journalLetter

9 Scopus citations

Effect of Seville orange juice and grapefruit juice on indinavir pharmacokinetics

Penzak, S. R., Acosta, E. P., Turner, M., Edwards, D. J., Hon, Y. Y., Desai, H. D. & Jann, M. W., 1 Oct 2002, In : Journal of Clinical Pharmacology. 42, 10, p. 1165-1170 6 p.

Research output: Contribution to journalArticle

37 Scopus citations

Influence of ritonavir on olanzapine pharmacokinetics in healthy volunteers

Penzak, S. R., Hon, Y. Y., Lawhorn, W. D., Shirley, K. L., Spratlin, V. & Jann, M. W., 5 Aug 2002, In : Journal of Clinical Psychopharmacology. 22, 4, p. 366-370 5 p.

Research output: Contribution to journalArticle

38 Scopus citations

Pharmacokinetics of fluvoxamine in relation to CYP2C19 phenotype and genotype

Jann, M. W., ZumBrunnen, T. L., Kazmi, Y. R., VanDenBerg, C. M., Desai, H. D., Weidler, D. J. & Flockhart, D. A., 9 Oct 2002, In : Drug Metabolism and Drug Interactions. 19, 1, p. 1-11 11 p.

Research output: Contribution to journalArticle

12 Scopus citations
2001

Contemporary drug treatment

Corey-Bloom, J., Geldmacher, D. S. & Jann, M. W., 15 Feb 2001, In : Patient Care. 35, 3, p. 54-67 14 p.

Research output: Contribution to journalArticle

Differences in haloperidol epidemiologic pharmacokinetic studies [9]

Jann, M. W., Chang, W. H. & Lane, H. Y., 17 Dec 2001, In : Journal of Clinical Psychopharmacology. 21, 6, p. 628-630 3 p.

Research output: Contribution to journalLetter

2 Scopus citations

Lack of CYP3A4 inhibition by grapefruit juice and ketoconazole upon clozapine administration in vivo

Lane, H. Y., Chiu, C. C., Kazmi, Y., Desai, H., Francis Lam, Y. W., Jann, M. W. & Chang, W. H., 1 Jan 2001, In : Drug Metabolism and Drug Interactions. 18, 3-4, p. 263-278 16 p.

Research output: Contribution to journalArticle

13 Scopus citations

Repeated ingestion of grapefruit juice does not alter clozapine's steady-state plasma levels, effectiveness, and tolerability

Lane, H. Y., Jann, M. W., Chang, Y. C., Chiu, C. C., Huang, M. C., Lee, S. H. & Chang, W. H., 1 Jan 2001, In : Journal of Clinical Psychiatry. 62, 10, p. 812-817 6 p.

Research output: Contribution to journalArticle

30 Scopus citations

Seville (sour) orange juice: Synephrine content and cardiovascular effects in normotensive adults

Penzak, S. R., Jann, M. W., Cold, J. A., Hori, Y. Y., Desai, H. D. & Gurley, B. J., 1 Jan 2001, In : Journal of Clinical Pharmacology. 41, 10, p. 1059-1063 5 p.

Research output: Contribution to journalArticle

85 Scopus citations

Smoking in patients receiving psychotrophic medications: A pharmacokinetic perspective

Desai, H. D., Seabolt, J. & Jann, M. W., 1 Jan 2001, In : CNS Drugs. 15, 6, p. 469-494 26 p.

Research output: Contribution to journalReview article

174 Scopus citations

The Impact of Cloning in Pharmaceutical Products and for Human Therapeutics

Jann, M. W., Shirley, K. L. & Falek, A., 1 Jan 2001, In : Global Bioethics. 14, 2-3, p. 47-51 5 p.

Research output: Contribution to journalArticle

Open Access
2000

An international symposium on psychopharmacology and ethnicity

Jann, M. W. & Montane Jaime, L. K., 1 Jan 2000, In : Drug Metabolism and Drug Interactions. 16, 1, p. 13-14 2 p.

Research output: Contribution to journalArticle

Cholinesterase inhibitors for the treatment of Alzheimer's disease in the elderly

VanDenBerg, C. M., Kazmi, Y. & Jann, M. W., 1 Jan 2000, In : Drugs and Aging. 16, 2, p. 123-138 16 p.

Research output: Contribution to journalReview article

29 Scopus citations

Clozapine pharmacokinetics and pharmacodynamics studied with CYP1A2-null mice

Aitchison, K. J., Jann, M. W., Zhao, J., Sakai, T., Zaher, H., Wolff, K., Collier, D., Kerwin, R. W. & Gonzalez, F. J., 1 Jan 2000, In : Journal of Psychopharmacology. 14, 4, p. 353-359 7 p.

Research output: Contribution to journalArticle

31 Scopus citations